Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
ImageneBio, Inc. roe for the quarter ending 2026-06-30 was -36.94%, a 407.63% decline year-over-year.
ImageneBio, Inc. roe for the quarter ending 2026-03-31 was -40.45%, a 437.47% decline year-over-year.
ImageneBio, Inc. roe for the quarter ending 2025-12-31 was -34.06%, a 249.56% decline year-over-year.
ImageneBio, Inc. roe for the quarter ending 2025-09-30 was -30.93%, a 192.20% decline year-over-year.
ImageneBio, Inc. roe for fiscal 2025 was -34.06%, a 249.56% decline from fiscal 2024.
ImageneBio, Inc. roe for fiscal 2024 was 22.77%, a 57.87% decline from fiscal 2023.
ImageneBio, Inc. roe for fiscal 2023 was 54.05%, a change of 100.84% from fiscal 2022.
ImageneBio, Inc. roe for fiscal 2022 was -46.79%, a change of -30.38% from fiscal 2021.